To reproduce the development of acquired resistance in patients, we treated two Notch-addicted, Notch1-mutated T-ALL patient-derived xenografts (PDX) (PDTALL11 and PDTALL1918; Supplementary Data 1), after systemic engraftment in NOD/SCID mice, with the Notch1-specific (aNotch1) neutralizing monoclonal antibody OMP52M51, until leukemia occurrence19 (Model n.3). This evidence concerns the gene NOTCH1 and leukemia.